Association between viral load of varicella zoster virus in cerebrospinal fluid and the clinical course of central nervous system infection

Diagnostic Microbiology and Infectious Disease

Volumn 79, Issue 2, 2014, Pages 174-177

  Rottenstreich, Amihai ^a,c   Oz, Zipi Kra ^b   Oren, Ilana ^a,c  

^a Unit of Infectious Diseases   (Israel)

^b Rambam Health Care Campus   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Central nervous system; Quantitative; Real time PCR; Varicella zoster virus

Indexed keywords

ACICLOVIR; VIRUS DNA;

ADULT; ARTICLE; CELL COUNT; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; ENCEPHALITIS; FEMALE; HERPES ZOSTER; HUMAN; HYPONATREMIA; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; VARICELLA ZOSTER VIRUS; VIRUS DETECTION; VIRUS LOAD; VIRUS REACTIVATION; ADOLESCENT; AGED; CHILD; HERPES ZOSTER ENCEPHALITIS; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY; SEVERITY OF ILLNESS INDEX; TIME; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CEREBROSPINAL FLUID; CHILD; DNA, VIRAL; ENCEPHALITIS, VARICELLA ZOSTER; FEMALE; HERPESVIRUS 3, HUMAN; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; TIME FACTORS; VIRAL LOAD; YOUNG ADULT;

EID: 84900495756     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2014.02.015     Document Type: Article

References (25)

1. Aberle S., Aberle J., Steininger C., Puchhammer- Stöckl E. Quantitative real time PCR detection of Varicella-zoster virus DNA in cerebrospinal fluid in patients with neurological disease. Med Microbiol Immunol 2005, 94:7-12.
2. Adair C.V., Gauld R.L., Smadel J.E. Aseptic meningitis, a disease of diverse etiology: clinical and etiologic studies on 854 cases. Ann Intern Med 1953, 39:675-704.
3. Bergstrom T. Polymerase chain reaction for diagnosis of varicella zoster virus central nervous system infections without skin manifestations. Scand J Infect Dis 1996, 100(Suppl):41-45.
4. Bhullar S.S., Chandak N.H., Purohit H.J., Taori G.M., Daginawala H.F., Kashyap R.S. Determination of viral load by quantitative real-time PCR in herpes simplex encephalitis patients. Intervirology 2014, 57:1-7.
5. Brisson M., Edmunds W.J., Law B., Gay N.J., Walld R., Brownell M., et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 2001, 127:305-314.
6. Burke B.L., Steele R.W., Beard O.W., Wood J.S., Cain T.D., Marmer D.J. Immune responses to varicella-zoster in the aged. Arch Intern Med 1982, 142:291-293.
7. Cunningham A.L., Dworkin R.H. The management of post-herpetic neuralgia. BMJ 2000, 321:778-779.
8. Donahue J.G., Choo P.W., Manson J.E., Platt R. The incidence of herpes zoster. Arch Intern Med 1995, 155:1605-1609.
9. Echevarria J.M., Casas I., Martinez-Martin P. Infections of the nervous system caused by varicella-zoster virus: a review. Intervirology 1997, 40:72-84.
10. Echevarria J.M., Casas I., Tenorio A., de Ory F., Martinez-Martin P. Detection of varicella-zoster virus-specific DNA sequences in cerebrospinal fluid from patients with acute aseptic meningitis and no cutaneous lesions. J Med Virol 1994, 43:331-335.
11. Gershon A.A., Gershon M.D., Breuer J., Levin M.J., Oaklander A.L., Griffiths P.D. Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol 2010, 48(Suppl 1):S2-S7.
12. Gilden D.H., Kleinschmidt-DeMasters B.K., Laguardia J.J., Mahalingam R., Cohrs R.J. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000, 342:635-645.
13. Glaser C.A., Honarmand S., Anderson L.J., Schnurr D.P., Forghani B., Cossen C.K., et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 2006, 43:1565-1577.
14. Hjalmarsson A., Granath F., Forsgren M., Brytting M., Blomqvist P., Skoldenberg B. Prognostic value of intrathecal antibody production and DNA viral load in cerebrospinal fluid of patients with herpes simplex encephalitis. J Neurol 2009, 256:1243-1251.
15. Horien C., Grose C. Neurovirulence of varicella and the live attenuated varicella vaccine virus. Semin Pediatr Neurol 2012, 19:124-129.
16. Karp S.J. Meningitis and disseminated cutaneous zoster complicating herpes zoster infection. J Neurol Neurosurg Psychiatry 1983, 46:582-583.
17. Koskiniemi M., Rantalaiho T., Piiparinen H., von Bonsdorff C.H., Farkkila M., Jarvinen A., et al. Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J Neurovirol 2001, 7:400-408. Study Group.
18. Miller E., Marshall R., Vurdien J. Epidemiology, outcome and control of varicella-zoster infection. Rev Med Microbiol 1993, 4:222-230.
19. Munoz-Almagro C., Jordan I., Cambra F.J., Esteban E., Urrea M., Garcia-Garcia J.J., et al. Quantitative real-time PCR in paediatric patients with herpes simplex infections of the central nervous system. J Virol Methods 2008, 47:297-300.
20. Pahud B.A., Glaser C.A., Dekker C.L., Arvin A.M., Schmid D.S. Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10years after the introduction of the varicella vaccine. J Infect Dis 2011, 203:316-323.
21. Persson A., Bergstrom T., Lindh M., Namvar L., Studahl M. Varicella-zoster virus CNS disease-viral load, clinical manifestations and sequels. J Clin Virol 2009, 46:249-253.
22. Poissy J., Champenois K., Dewilde A., Melliez H., Georges H., Senneville E., et al. Impact of Herpes simplex virus load and red blood cells in cerebrospinal fluid upon herpes simplex meningo-encephalitis outcome. BMC Infect Dis 2012, 12:356.
23. Schloss L., Falk K.I., Skoog E., Brytting M., Linde A., Aurelius E. Monitoring of herpes simplex virus DNA types 1 and 2 viral load in cerebrospinal fluid by real-time PCR in patients with herpes simplex encephalitis. J Med Virol 2009, 81:1432-1437.
24. Weinberg A., Li S., Palmer M., Tyler K.L. Quantitative CSF PCR in Epstein-Barr virus infections of the central nervous system. Ann Neurol 2002, 2:543-548.
25. Ziyaeyan M., Alborzi A., Borhani Haghighi A., Jamalidoust M., Moeini M., Pourabbas B. Diagnosis and quantitative detection of HSV DNA in samples from patients with suspected herpes simplex encephalitis. Braz J Infect Dis 2011, 5:211-214.